Search results

ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.

ANSTO has a range of capabilities and expertise to support aerospace and space research.

ANSTO is home to over AUD$1.3B state of the art instruments and science technology. To access ANSTO’s world-leading and highly specialised facilities and capabilities, please contact our Industry Engagement team. This way we can co-ordinate your enquiry and provide advice on your application.

2022 has been a big year for ANSTO with contributions to the advanced manufacturing, space, food, energy industries, and more. As we set our sights on 2023, we thought we’d take the opportunity to share some of our key innovation achievements from this year.

ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

What’s it like being a graduate at ANSTO? Read these profiles featuring some of our many graduates and scholarship recipients.

To enable the production of nuclear medicine, ANSTO operates manufacturing, processing and distribution facilities in Sydney.

ANSTO manufacture and supply a range of radiopharmaceuticals, radiochemicals, kits and accessories for use in research, industry and the health sector.